A prospective double blind randomized controlled study on the use of ethanol locks in HPN patients

Bradley R. Salonen, Sara L. Bonnes, Nishanth Vallumsetla, Jithinraj Edakkanambeth Varayil, Manpreet S. Mundi, Ryan T Hurt

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background & aims: Ethanol lock therapy (ELT) has been shown to reduce the rate of catheter-related bloodstream infection (CRBSI) in high-risk home parenteral nutrition (HPN) patients. The aim of this study was to determine whether ELT therapy for all patients newly started on HPN would reduce the incidence of CRBSI. Methods: This study was a prospective, double-blind, randomized controlled trial that was carried out from July 2014 to April 2016. The study participants were patients newly started on HPN, and they were randomly assigned to either treatment with ELT or our current standard of care with saline heparin locks. The primary outcome was occurrence of CRBSI. Results: Thirty eight patients that were newly started on HPN were randomized to either treatment with ELT (n = 18) or to our current standard of care with heparin locks (n = 20). Four patients in the ELT group and one patient in the control arm had a CRBSI (p = 0.17). No significant adverse side effects were noted during the study. Conclusions: This study did not show improvement in the rate of CRBSI with ELT in all patients started on HPN. ELT therapy may be most helpful to reduce in CRBSI in high-risk HPN patients, but further studies with a randomized control trial design of high-risk patients are needed to further clarify this important issue in HPN patients.The study was registered at clinicaltrials.gov prior to patient enrollment (NCT02227329).

Original languageEnglish (US)
JournalClinical Nutrition
DOIs
StateAccepted/In press - Jan 17 2017

Fingerprint

Home Parenteral Nutrition
Ethanol
Catheter-Related Infections
Therapeutics
Standard of Care
Heparin
Group Psychotherapy

Keywords

  • Adult
  • Catheter-related bloodstream infection
  • Ethanol lock
  • Home parenteral nutrition

ASJC Scopus subject areas

  • Nutrition and Dietetics
  • Critical Care and Intensive Care Medicine

Cite this

A prospective double blind randomized controlled study on the use of ethanol locks in HPN patients. / Salonen, Bradley R.; Bonnes, Sara L.; Vallumsetla, Nishanth; Varayil, Jithinraj Edakkanambeth; Mundi, Manpreet S.; Hurt, Ryan T.

In: Clinical Nutrition, 17.01.2017.

Research output: Contribution to journalArticle

Salonen, Bradley R. ; Bonnes, Sara L. ; Vallumsetla, Nishanth ; Varayil, Jithinraj Edakkanambeth ; Mundi, Manpreet S. ; Hurt, Ryan T. / A prospective double blind randomized controlled study on the use of ethanol locks in HPN patients. In: Clinical Nutrition. 2017.
@article{0f08c39d722a4b0c89e19bb0050126e6,
title = "A prospective double blind randomized controlled study on the use of ethanol locks in HPN patients",
abstract = "Background & aims: Ethanol lock therapy (ELT) has been shown to reduce the rate of catheter-related bloodstream infection (CRBSI) in high-risk home parenteral nutrition (HPN) patients. The aim of this study was to determine whether ELT therapy for all patients newly started on HPN would reduce the incidence of CRBSI. Methods: This study was a prospective, double-blind, randomized controlled trial that was carried out from July 2014 to April 2016. The study participants were patients newly started on HPN, and they were randomly assigned to either treatment with ELT or our current standard of care with saline heparin locks. The primary outcome was occurrence of CRBSI. Results: Thirty eight patients that were newly started on HPN were randomized to either treatment with ELT (n = 18) or to our current standard of care with heparin locks (n = 20). Four patients in the ELT group and one patient in the control arm had a CRBSI (p = 0.17). No significant adverse side effects were noted during the study. Conclusions: This study did not show improvement in the rate of CRBSI with ELT in all patients started on HPN. ELT therapy may be most helpful to reduce in CRBSI in high-risk HPN patients, but further studies with a randomized control trial design of high-risk patients are needed to further clarify this important issue in HPN patients.The study was registered at clinicaltrials.gov prior to patient enrollment (NCT02227329).",
keywords = "Adult, Catheter-related bloodstream infection, Ethanol lock, Home parenteral nutrition",
author = "Salonen, {Bradley R.} and Bonnes, {Sara L.} and Nishanth Vallumsetla and Varayil, {Jithinraj Edakkanambeth} and Mundi, {Manpreet S.} and Hurt, {Ryan T}",
year = "2017",
month = "1",
day = "17",
doi = "10.1016/j.clnu.2017.05.009",
language = "English (US)",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - A prospective double blind randomized controlled study on the use of ethanol locks in HPN patients

AU - Salonen, Bradley R.

AU - Bonnes, Sara L.

AU - Vallumsetla, Nishanth

AU - Varayil, Jithinraj Edakkanambeth

AU - Mundi, Manpreet S.

AU - Hurt, Ryan T

PY - 2017/1/17

Y1 - 2017/1/17

N2 - Background & aims: Ethanol lock therapy (ELT) has been shown to reduce the rate of catheter-related bloodstream infection (CRBSI) in high-risk home parenteral nutrition (HPN) patients. The aim of this study was to determine whether ELT therapy for all patients newly started on HPN would reduce the incidence of CRBSI. Methods: This study was a prospective, double-blind, randomized controlled trial that was carried out from July 2014 to April 2016. The study participants were patients newly started on HPN, and they were randomly assigned to either treatment with ELT or our current standard of care with saline heparin locks. The primary outcome was occurrence of CRBSI. Results: Thirty eight patients that were newly started on HPN were randomized to either treatment with ELT (n = 18) or to our current standard of care with heparin locks (n = 20). Four patients in the ELT group and one patient in the control arm had a CRBSI (p = 0.17). No significant adverse side effects were noted during the study. Conclusions: This study did not show improvement in the rate of CRBSI with ELT in all patients started on HPN. ELT therapy may be most helpful to reduce in CRBSI in high-risk HPN patients, but further studies with a randomized control trial design of high-risk patients are needed to further clarify this important issue in HPN patients.The study was registered at clinicaltrials.gov prior to patient enrollment (NCT02227329).

AB - Background & aims: Ethanol lock therapy (ELT) has been shown to reduce the rate of catheter-related bloodstream infection (CRBSI) in high-risk home parenteral nutrition (HPN) patients. The aim of this study was to determine whether ELT therapy for all patients newly started on HPN would reduce the incidence of CRBSI. Methods: This study was a prospective, double-blind, randomized controlled trial that was carried out from July 2014 to April 2016. The study participants were patients newly started on HPN, and they were randomly assigned to either treatment with ELT or our current standard of care with saline heparin locks. The primary outcome was occurrence of CRBSI. Results: Thirty eight patients that were newly started on HPN were randomized to either treatment with ELT (n = 18) or to our current standard of care with heparin locks (n = 20). Four patients in the ELT group and one patient in the control arm had a CRBSI (p = 0.17). No significant adverse side effects were noted during the study. Conclusions: This study did not show improvement in the rate of CRBSI with ELT in all patients started on HPN. ELT therapy may be most helpful to reduce in CRBSI in high-risk HPN patients, but further studies with a randomized control trial design of high-risk patients are needed to further clarify this important issue in HPN patients.The study was registered at clinicaltrials.gov prior to patient enrollment (NCT02227329).

KW - Adult

KW - Catheter-related bloodstream infection

KW - Ethanol lock

KW - Home parenteral nutrition

UR - http://www.scopus.com/inward/record.url?scp=85019741913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019741913&partnerID=8YFLogxK

U2 - 10.1016/j.clnu.2017.05.009

DO - 10.1016/j.clnu.2017.05.009

M3 - Article

C2 - 28576557

AN - SCOPUS:85019741913

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

ER -